Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis

OBJECTIVE: To assess the efficacy and tolerability of tocilizumab in a multicenter, randomized, double‐blind, placebo‐controlled trial in refractory adult patients with dermatomyositis (DM) and polymyositis (PM). METHODS: Thirty‐six subjects with probable or definite DM/PM were enrolled in a 6‐month...

Descripción completa

Detalles Bibliográficos
Autores principales: Oddis, Chester V., Rockette, Howard E., Zhu, Lei, Koontz, Diane C., Lacomis, David, Venturupalli, Swamy, Moghadam‐Kia, Siamak, Ascherman, Dana P., Crofford, Leslie, Dimachkie, Mazen M., Ernste, Floranne, Gazeley, David, Marder, Galina, Aggarwal, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661830/
https://www.ncbi.nlm.nih.gov/pubmed/36128663
http://dx.doi.org/10.1002/acr2.11493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661830/
https://www.ncbi.nlm.nih.gov/pubmed/36128663
http://dx.doi.org/10.1002/acr2.11493

Ejemplares similares